Boston Scientific Corp (BSX)
Receivables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 16,747,000 | 14,240,000 | 12,682,000 | 11,888,000 | 9,913,000 |
Receivables | US$ in thousands | — | — | — | — | — |
Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $16,747,000K ÷ $—K
= —
Based on the provided data, Boston Scientific Corp's receivables turnover ratio is unavailable for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. This lack of information hinders a detailed analysis of the company's efficiency in collecting its accounts receivable within a specific period.
Further examination of this ratio in the future may provide insight into Boston Scientific Corp's effectiveness in managing its credit extending and collection processes.
Peer comparison
Dec 31, 2024
Company name
Symbol
Receivables turnover
Boston Scientific Corp
BSX
—
3M Company
MMM
7.69
Artivion Inc
AORT
—
Baxter International Inc
BAX
—
Becton Dickinson and Company
BDX
6.65
DexCom Inc
DXCM
—
Embecta Corp
EMBC
4.53
Glaukos Corp
GKOS
6.23
Globus Medical
GMED
—
Haemonetics Corporation
HAE
12.56
ICU Medical Inc
ICUI
—